• Muller-Fleurisson C
  • SPECanin 2005
  • Novembre 2005
  • : Cancérologie
  • : Chien, chat

1- Bastan A, Zonturlu AK. Investigation of the relationship between age and tumour characteristics ans localization in dogs with mammary tumours. Ankara Universitesi Veteriner Fakultesi Dergisi. 2002;49: 203-206.
2- Bruun ET. Oestrus control in the bitch with medroxyprogesterone (MPA) and the prevalence of mammary tumours. Dansk Veterinaer tidsskrift. 1996;79: 523-526.
3- De las Mulas M, Ordas J, Millan MY et coll. Immunohistochemical expression of estrogen receptor beta in normal and tumoral canine mammary glands. Vet. Pathol. 2004; 41:269-272.
4- DonnayI, RauisJ, Vertsegen J. Influence des antécédents hormonaux sur l'apparition clinique de tumeurs mammaires chez la chienne. Ann. Méd. Vét. 1994;138: 109-117.
5- Djupsjöbacka A, Eksell D. Frequency of radiographically detected pulmonary metastases in bitches with mammary gland neoplasia. SvenskVeterinär Tidning. 2001; 53; 11: 557-563.
6- Gobello C, Corrada Y. Canine mammary tumors : an endocrine clinical approach. Compend. Contin. Educ. Vet. Pract.2001;23(8): 705-710.
7- Graham JC, O'Keefe DA, Gelberg HB. Immunohistochemical assay for detecting estrogen receptors in canine mammary tumors. Am. J. Vet. Res. 1999;60(5):627-630.
8- Hahn KA, Richardson RC, Knapp DW. Canine malignant mammary neoplasia: biological behavior, diagnosis, and treatment alternatives. J. Am. Anim. Hosp. Assoc. 1992; 28:251-256.
9- Hellmen E, Bergstrom R, Holmberg L et coll. Prognostic factors in canine mammary tumors; a multivariate study of 202 consecutive cases. Vet. Pathol. 1993;30(1):20-27.
10- Lagadic M. Cohn-Bendit F. Les tumeurs mammaires dans l'espèce canine. Prat. Med. Chir. Anim. Comp. 1995;30:437-451.
11- Magnol JP, Marchal Th, Delisle F et coll. Cancérologie clinique du chien. A compte d'auter. Lezay. 1998. 426 pages.
12- Morris JS, Dobson JM, Bostock DE et coll. Effect of ovariohysterectomy in bitches with mammary neoplasms. Vet. Record. 1998; 142: 656-658.
13- Nieto A, Pena L, Perez Alenza MD et coll. Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: clinical and pathologic associations and prognostic significance. Vet. Pathol. 2000;37(3):239-247.
14- Ogilvie GK, Moore AS. Manuel pratique de cancérologie vétérinaire. Editions Masson. Paris. 1997. 539 pages.
15- Ogilvie GK, Moore AS. Feline Oncology : a comprehensive guide to compassionate care. Veterinary Learning System. Trenton. 2001. 503 pages.
16- Pena LL, Nieto AI, Perez Alenza D et coll. Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors : relationship to clinical and pathological variables. J. Vet. Diagn. Invest. 1998;10(3):237-246.
17- Perez Alenza MD, Rutteman G, Pena L et coll. Relation between habitual diet and canine mammary tumors in a case-control study. J. Vet. Intern. Med. 1998; 12: 132-139.
18- Perez Alenza MD, Tabanera E, Pena L. Inflammatory mammary carcinoma in dogs : 33 cases (1995-1999). J. Am. Vet. Med. Assoc. 2001;219(8):1110-1114.
19- Sautet JY, Ruberte J, Lopez C et coll. Lymphatic system of the mammary glands in the dog : approach to the surgical treatment of malignant mammary tumors. Canine Pract. 1992; 17(2):30-33.
20- Schafer-Somi S, Konig G, Aurich JE. Juvenile and prepubertal neutering of dogs and cats. Wiener Tierarztliche Monatsschrift. 2003; 90: 160-168.
21- Sorenmo KU, Shofer FS, Goldschmidt MH. Effects of spaying and timing on spaying on survival of dogs with mammary carcinoma. J. Vet. Intern. Med. 2000; 14: 266-270.
22- Van Os JL. Oestrus control in the bitch with proligestone. Thesis. Utrecht. 1982:219-239.
23- Verstegen J, Scalais S, Onclin K. La cabergoline lors de tumeurs mammaires en pseudogestation. Point Vet. 2004;249:10-11.
24- Verstegen J, Scalais S, Onclin K. Tumeurs mammaires et prolactine. Point Vet. 2004;249:44-46.
25- Viste JR. Feline mammary adenocarcinoma : tumor size as a prognostic indicator. Can. Vet. J. 2002; 43(1): 33-37.
26- Waters DJ, Honeckman A, Cooley DM et coll. Skeletal metastasis in feline mammary carcinoma: case report and literature review. J. Am. Anim. Hosp. Assoc. 1998; 34:103-108.
27- Wey N, Kohn B, Gutberlet K et coll. Mammary tumours in the bitch : clinical follow-up study (1995-1997). Kleintierpraxis. 1999;44:565-578.
28- Withrow SJ, Mac Ewen EG. Clinical veterinary oncology. First edition. Lippincott company. Philadelphia. 1989. 457-459.
29- Zuccari DA, Santana AE, Rocha NS et coll. Fine needle aspiration cytologic and histologic correlation in canine mammary tumors. Braz. J. Vet. Res. Anim. Sci. 2001;38(1-6):38-41.
30- Zuccari DA, Santana AE, Cury PM et coll. Immunocytochemical study of Ki-67 as a prognostic marker in canine mammary neoplasia. Vet. Clin. Pathol. 2004; 33(1):23-28.


En poursuivant votre navigation sur ce site, vous acceptez l’utilisation de cookies pour vous proposer des services et offres adaptés à vos centres d’intérêts.X
Pour en savoir plus et paramétrer les cookies...